Clinical Trial Update: Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating Sintilimab plus chemoradiotherapy followed by D2 gastrectomy in advanced gastric cancer with retroperitoneal lymph node meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Ruijin Hospital | Conditions: Gastric Cancer | Phase 2, Phase 3 | Status: UNKNOWN